tiprankstipranks

New Portfolio - New Portfolio

Saulius Alisauskas

New Portfolio
Individual Investor
Ranked #476,668 out of 783,619 TipRanks' Investors
Success Rate
38%
9 out of 24
profitable transactions
Average Return
-4.98%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 21.75%
6-Month Return▼ 14.53%
12-Month Return-
YTD Return▼ 21.75%
Total Return▼ 15.54%

Best Trade

Opened at
Closed at
Gain▲ 84.87%

Bio

Performance

26.04%0-26.04%
▲ 9.79%
▲ 3.53%
▲ 17.02%
Jun 2024
▲ 8.13%
▲ 1.21%
▲ 3.84%
Jul 2024
▼ 13.14%
▲ 2.34%
▼ 7.74%
Aug 2024
▲ 2.93%
▲ 2.10%
▲ 13.51%
Sep 2024
▲ 9.99%
▼ 0.89%
▲ 3.05%
Oct 2024
▲ 26.04%
▲ 5.96%
▲ 9.45%
Nov 2024
▲ 5.93%
▼ 2.41%
▼ 7.54%
Dec 2024
▲ 3.19%
▲ 2.68%
▼ 21.75%
Jan 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 9.79%▲ 3.53%▲ 17.02%
▲ 8.13%▲ 1.21%▲ 3.84%
▼ 13.14%▲ 2.34%▼ 7.74%
▲ 2.93%▲ 2.10%▲ 13.51%
▲ 9.99%▼ 0.89%▲ 3.05%
▲ 26.04%▲ 5.96%▲ 9.45%
▲ 5.93%▼ 2.41%▼ 7.54%
▲ 3.19%▲ 2.68%▼ 21.75%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
UAV
0%
▼ 38.98%
1
Open
Jan 16, 2025
Syros Pharmaceuticals
0%
▼ 90.29%
1
Open
Aug 20, 2024
Mynaric AG
0%
▼ 72.85%
1
Open
Aug 20, 2024
YieldMax COIN Option Income Strategy ETF
0%
▲ 52.27%
1
Open
Aug 07, 2024
FibroGen
0%
▲ 6.81%
1
Open
Aug 01, 2024
Nvidia
0%
▼ 1.50%
2
Sell
Jul 30, 2024
SeaStar Medical Holding
▲ 78.68%
3
Close
Jun 21, 2024
MicroCloud Hologram
▼ 0.13%
2
Close
Jun 21, 2024
Taysha Gene Therapies
4.02%
▼ 50.17%
1
Open
Jun 18, 2024
Realty Income
▼ 1.78%
2
Close
Jun 17, 2024
Ovid Therapeutics
51.14%
▼ 11.28%
1
Open
Jun 17, 2024
Aerovate Therapeutics
0%
▲ 58.79%
1
Open
Jun 17, 2024
TSMC
▲ 2.25%
2
Close
Jun 11, 2024
Roblox
▲ 7.97%
2
Close
Jun 06, 2024
MacroGenics
44.84%
▼ 37.39%
2
Buy
Jun 05, 2024
CytomX Therapeutics
▼ 14.80%
2
Close
Jun 05, 2024
Lyra Therapeutics
▼ 9.86%
2
Close
Jun 05, 2024
Mobile-health Network Solutions Class A
▼ 15.86%
2
Close
Jun 05, 2024
Spruce Biosciences
▲ 10.96%
3
Close
May 15, 2024
Better Therapeutics, Inc.
▼ 35.29%
2
Close
May 15, 2024